149 related articles for article (PubMed ID: 26369624)
21. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients.
Correia-Silva Jde F; Victória JM; Guimarães AL; Salomão UE; de Abreu MH; Bittencourt H; Gomez RS
Oral Dis; 2007 Mar; 13(2):163-9. PubMed ID: 17305617
[TBL] [Abstract][Full Text] [Related]
23. Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients.
Nash T; Hoffmann S; Butch S; Davenport R; Cooling L
Transfusion; 2012 Oct; 52(10):2270-2. PubMed ID: 23110735
[No Abstract] [Full Text] [Related]
24. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China.
Wu X; Wang Y; Xu Y; Wu D; Sun A; Zhu Z; Han Y; Qiu H; Tang X; Fu Z; He G; Li C; Ma X; Liu Y
Biol Blood Marrow Transplant; 2010 May; 16(5):647-52. PubMed ID: 20025986
[TBL] [Abstract][Full Text] [Related]
26. Utility of antigenemia test for cytomegalovirus detection in hematopoietic transplant recipients: report of experiences from Medellín, Colombia.
Sarmiento-Maldonado M; Eugenia Castaño-Orozco M; Bedoya-Escobar VI; Calle-Fernandez S; Velásquez-Lopera M; Gomez-Wolff R; Karduss Urueta A; Cuellar-Ambrosi F
Bone Marrow Transplant; 2003 Jul; 32(1):119-20. PubMed ID: 12815489
[No Abstract] [Full Text] [Related]
27. Cytomegalovirus glycoprotein B and N genotypes in pediatric recipients of the hematopoietic stem cell transplant.
Janković M; Ćupić M; Knežević A; Vujić D; Soldatović I; Zečević Ž; Gobeljić B; Jovanović T
Virology; 2020 Sep; 548():168-173. PubMed ID: 32838938
[TBL] [Abstract][Full Text] [Related]
28. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
[TBL] [Abstract][Full Text] [Related]
30. Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity.
Herling M; Schröder L; Awerkiew S; Chakupurakal G; Holtick U; Kaiser R; Pfister H; Scheid C; Di Cristanziano V
J Clin Virol; 2016 Jan; 74():57-60. PubMed ID: 26672492
[TBL] [Abstract][Full Text] [Related]
31. The role of adenotonsillectomy in graft-versus-host disease.
Schwab B; Raynor E
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):57-60. PubMed ID: 22018926
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms.
Liu A; Meyer E; Johnston L; Brown J; Gerson LB
Aliment Pharmacol Ther; 2013 Oct; 38(8):955-66. PubMed ID: 24003975
[TBL] [Abstract][Full Text] [Related]
34. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
Du J; Liu J; Gu J; Zhu P
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
[TBL] [Abstract][Full Text] [Related]
35. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
36. The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation.
Rowe J; Grim SA; Peace D; Lai C; Sweiss K; Layden JE; Clark NM
Clin Transplant; 2013; 27(4):510-6. PubMed ID: 23621704
[TBL] [Abstract][Full Text] [Related]
37. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
[TBL] [Abstract][Full Text] [Related]
38. Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease.
Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Proctor SJ; Hamilton PJ; Cant AJ
Bone Marrow Transplant; 1995 Apr; 15(4):557-61. PubMed ID: 7655381
[TBL] [Abstract][Full Text] [Related]
39. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
40. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]